text
"['\n4. 매출 및 수주상황\n가. 매출실적 ( 내부거래 제거전 현황임. \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 단, 제일약품 매출 현황은 연결 매출액 기준으로 작성)\n(단위 :천원 \xa0)\n사업부문\n매출유형\n품 목\n\xa0제65기분기\n\xa0제64기연간\n\xa0제63기연간\n의약품제조\n제품\n케펜텍\n수출\n8,469,790\n9,900,944\n11,171,437\n내수\n4,333,750\n5,949,498\n5,557,305\n쿨파프\n수출\n1,495,056\n2,405,869\n2,703,966\n내수\n1,358,505\n1,755,016\n511,847\n티에스원\n내수\n3,789,574\n4,728,027\n4,837,090\n넥실렌\n내수\n6,294,294\n9,021,663\n8,119,548\n로제듀오\n내수\n16,413,007\n-\n-\n크라비트\n수출\n411,177\n219,033\n210,641\n내수\n4,259,041\n5,882,351\n5,031,389\n베라실\n내수\n5,513,657\n7,525,718\n6,210,710\n란스톤캡슐\n내수\n4,519,386\n7,215,395\n7,501,507\n스타브론\n내수\n3,928,079\n5,216,617\n5,079,411\n비유피-4\n내수\n5,338,132\n6,686,889\n5,448,142\n필그렐정\n내수\n7,130,696\n8,030,598\n6,693,269\n리피토플러스\n내수\n16,881,933\n14,109,669\n7,510,322\n기타\n수출\n15,703,231\n20,600,370\n23,049,246\n내수\n64,517,943\n78,564,382\n71,743,050\n합계\n80,221,174\n99,164,752\n94,792,296\n소계\n수출\n26,079,254\n33,126,216\n37,135,290\n내수\n144,277,997\n154,685,823\n134,243,590\n합계\n170,357,251\n187,812,039\n171,378,880\n상품\n리피토\n내수\n122,860,418\n172,912,239\n182,910,705\n리리카\n내수\n55,652,664\n77,170,802\n72,077,548\n쎄레브렉스\n내수\n29,455,302\n48,519,201\n47,876,800\n란스톤엘에프디티\n내수\n16,072,414\n23,675,996\n24,629,539\n뉴론틴\n내수\n14,612,410\n24,160,933\n23,976,814\n카듀엣\n내수\n11,371,706\n17,659,657\n18,487,639\n덱실란트 디알 캡슐\n내수\n13,569,292\n19,725,106\n20,973,859\n진정주비타\n내수\n-\n1,065,247\n3,320,756\n투엑스비 듀얼\n내수\n519,301\n2,692,664\n3,481,568\n한방파프수\n내수\n3,975,644\n4,972,975\n3,340,254\n록펜텍\n내수\n1,335,835\n2,019,028\n1,387,109\n기타\n수출\n2,685,761\n739,466\n24,471,452\n내수\n118,717,376\n184,781,414\n185,867,369\n합계\n121,403,137\n185,520,880\n210,338,821\n소계\n수출\n2,685,761\n739,466\n24,471,452\n내수\n388,142,362\n579,355,262\n588,329,960\n합계\n390,828,123\n580,094,728\n612,801,412\n기타\n수탁매출외\n내수\n6,104,668\n24,836,624\n5,605,600\n지주사외\n기타\n경영자문\n내수\n3,313,679\n4,035,697\n3,832,254\n임대료\n내수\n3,860,311\n5,029,031\n4,874,296\n지분법수익\n내수\n3,645,657\n4,622,649\n2,907,054\n판매대행\n내수\n19,957,909\n25,656,158\n23,495,232\n합 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0계\n수출\n28,765,015\n33,865,682\n61,606,742\n내수\n569,302,583\n798,221,244\n763,287,986\n합계\n598,067,598\n832,086,926\n824,894,728\n나. 판매경로 및 판매방법 등\n(1) 판매경로\n\xa0[제일약품] \xa0 \xa0 원외 \xa0 \xa0 \xa0 : \xa0 84.9% \xa0 \xa0 \xa0 종합병원 : \xa0 \xa07.1% \xa0 \xa0 \xa0 \xa0 \xa0관계사 \xa0 \xa0: \xa0 \xa0 0.8%  \xa0 \xa0 기타 \xa0 \xa0 \xa0 : \xa0 \xa03.9% \xa0 \xa0 \xa0 \xa0수출 \xa0 \xa0 \xa0 : \xa0 \xa03.3% [제일헬스사이언스] \xa0 \xa0약국 \xa0 \xa0: \xa0 55.4% \xa0 \xa0 \xa0 \xa0 \xa0 도매 \xa0 \xa0: \xa0 \xa09.6% \xa0 \xa0 \xa0 \xa0 \xa0특판 \xa0 \xa0: \xa0 \xa07.8%  \xa0 기타 \xa0 \xa0: \xa0 \xa0 6.7% \xa0 \xa0 \xa0 \xa0 \xa0 \xa0수출 \xa0 \xa0: \xa0 \xa020.5%\n(2) 판매방법 및 조건\n\xa0 방법 : 주문판매 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0조건 : 외상매출후 현금, 어음, 카드등 수금\n']"
